ARCHIVES

Gleevec Approved For Pediatric CML

This article is from The Cancer Letter archive.

Vol. 29 No. 21 | May 23, 2003

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

October 27, 2006

Tykerb And Trastuzumab Showed Increase In PFS For HER2+ Breast Cancer In Study

May 30, 2008

Includes 8-page April 2002 Business & Regulatory Report.

May 3, 2002

Also Senate, House committees request further research, reports from NCI.

September 19, 2003

NCI-Approved Clinical Trials

December 31, 2004

New Phone Number For Customer Service For The Cancer Letter

February 6, 1998